Finnish researchers E. Hemminki, H.K. Toiviainen, and L. Vuorenkoski reported that drug companies see patient group sponsorship as a means to inform patients about their products and to move their medicines to a more favourable reimbursement class.

The full article, titled Co-operation between patient organisations and the drug industry in Finland, was published in Social Science & Medicine in February 2010.

Katrina Perehudoff